Data / Drug companies / Famotidine, calcium carbonate and magnesium hydroxide
Famotidine, calcium carbonate and magnesium hydroxide: 20 companies and 23 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Famotidine, calcium carbonate and magnesium hydroxide is listed in the FDA National Drug Code Directory by 20 companies, with 23 products in commercial distribution. 23 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, chewable, and the newest product started marketing on July 16, 2026.
The request: Get every company that lists famotidine, calcium carbonate and magnesium hydroxide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 20
- Products
- 23
- Generic (ANDA) products
- 23 (100.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Dual Action Complete, Basic Care Dual Action Complete, Signature Care Acid Reducer Complete, Equaline Complete Dual Action, DG Health Acid Reducer Complete, Up and Up Dual Action Acid Reducer Antacid, Acid Reducer Complete, Good Sense Dual Action Complete
- openFDA record search
- api.fda.gov
Companies that list famotidine, calcium carbonate and magnesium hydroxide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amazon.com Services LLC | 2 | tablet, chewable | Generic drugs (ANDA) | July 16, 2026 |
| L. Perrigo Company | 2 | tablet, chewable | Generic drugs (ANDA) | August 9, 2022 |
| Safeway | 2 | tablet, chewable | Generic drugs (ANDA) | August 22, 2025 |
| American Sales Company | 1 | tablet, chewable | Generic drugs (ANDA) | September 29, 2016 |
| Amerisource Bergen | 1 | tablet, chewable | Generic drugs (ANDA) | March 10, 2026 |
| CVS Pharmacy | 1 | tablet, chewable | Generic drugs (ANDA) | February 11, 2016 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | tablet, chewable | Generic drugs (ANDA) | July 13, 2026 |
| Cardinal Health 110, LLC. DBA Leader | 1 | tablet, chewable | Generic drugs (ANDA) | December 14, 2021 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet, chewable | Generic drugs (ANDA) | December 27, 2018 |
| H E B | 1 | tablet, chewable | Generic drugs (ANDA) | April 7, 2016 |
| HyVee Inc | 1 | tablet, chewable | Generic drugs (ANDA) | August 11, 2008 |
| Kroger Company | 1 | tablet, chewable | Generic drugs (ANDA) | February 1, 2016 |
| Meijer Distribution Inc | 1 | tablet, chewable | Generic drugs (ANDA) | January 26, 2016 |
| Publix Super Markets Inc | 1 | tablet, chewable | Generic drugs (ANDA) | November 6, 2018 |
| Strategic Sourcing Services LLC | 1 | tablet, chewable | Generic drugs (ANDA) | October 31, 2023 |
| Target Corporation | 1 | tablet, chewable | Generic drugs (ANDA) | January 8, 2025 |
| Topco Associates LLC | 1 | tablet, chewable | Generic drugs (ANDA) | February 29, 2016 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet, chewable | Generic drugs (ANDA) | September 2, 2008 |
| Wal-Mart Stores Inc | 1 | tablet, chewable | Generic drugs (ANDA) | August 8, 2008 |
| Walgreen Company | 1 | tablet, chewable | Generic drugs (ANDA) | January 29, 2016 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 23 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 23 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Calculi Dissolution Agent | 23 |
| Histamine-2 Receptor Antagonist | 23 |
| Osmotic Laxative | 23 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.